{"id":205136,"name":"EYEPOINT PHARMACEUTICALS, INC.","slug":"eyepoint-pharmaceuticals-inc","state":"MA","country":"United States of America","description":"Specialty biopharmaceutical company.","totalSpending":1000000,"filings":15,"yearlySpending":[{"year":2020,"income":360000},{"year":2021,"income":320000},{"year":2022,"income":320000},{"year":2023,"income":0}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["FORBES-TATE"],"lobbyists":["ZACHARY WILLIAMS","ELIZABETH GREER","JEFFREY FORBES","BARRETT THORNHILL","DERRICK WHITE","MICHAEL WILLIAMS"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)"],"sampleDescriptions":["Issues related to healthcare.","General issues related to healthcare.","Issues related to improving patient access for advanced ophthalmic products.","General issues related to healthcare.","Issues related to improving patient access for advanced ophthalmic products."]}